Long-term central venous catheter use and risk of infection in older adults with cancer

Journal of Clinical Oncology

Volumn 32, Issue 22, 2014, Pages 2351-2356

  Lipitz Snyderman, Allison ^a   Sepkowitz, Kent A ^a   Elkin, Elena B ^a   Pinheiro, Laura C ^a   Sima, Camelia S ^a   Son, Crystal H ^a   Atoria, Coral L ^a   Bach, Peter B ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; BREAST CANCER; CANCER LOCALIZATION; CANCER PATIENT; CATHETER INFECTION; CENTRAL VENOUS CATHETER; CENTRAL VENOUS CATHETERIZATION; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HEAD AND NECK CANCER; HUMAN; INFECTION RATE; INFECTION RISK; LONG TERM CARE; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; PANCREAS CANCER; PRIORITY JOURNAL; RETROSPECTIVE STUDY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CATHETER-RELATED INFECTIONS; CENTRAL VENOUS CATHETERS; COHORT STUDIES; FEMALE; HUMANS; MALE; NEOPLASMS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; SEER PROGRAM; UNITED STATES;

EID: 84905845233     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2013.53.3018     Document Type: Article

References (24)

1. Kamboj M, Sepkowitz KA: Nosocomial infections in patients with cancer. Lancet Oncol 10:589- 597, 2009
2. Safdar A, Bodey G, Armstrong D: Infections in patients with cancer: Overview, in Safdar A (ed): Principles and Practice of Cancer Infectious Diseases. Berlin, Germany, Springer, 2011
3. Boersma RS, Jie KS, Verbon A, et al: Thrombotic and infectious complications of central venous catheters in patients with hematological malignancies. Ann Oncol 19:433-442, 2008 (Pubitemid 351325662)
4. Maki DG, Kluger DM, Crnich CJ: The risk of bloodstream infection in adults with different intravascular devices: A systematic review of 200 published prospective studies. Mayo Clin Proc 81:1159-1171, 2006 (Pubitemid 44316281)
5. Schiffer CA, Mangu PB, Wade JC, et al: Central venous catheter care for the patient with cancer: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol 31:1357-1370, 2013
6. O'Grady NP, Alexander M, Burns LA, et al: Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis 52:e162-e193, 2011
7. Yokoe DS, Mermel LA, Anderson DJ, et al: A compendium of strategies to prevent healthcare-associated infections in acute care hospitals. Infect Control Hosp Epidemiol 29:S12-S21, 2008 (suppl 1)
8. Penel N, Neu JC, Clisant S, et al: Risk factors for early catheter-related infections in cancer patients. Cancer 110:1586-1592, 2007 (Pubitemid 47463074)
9. Groeger JS, Lucas AB, Thaler HT, et al: Infectious morbidity associated with long-term use of venous access devices in patients with cancer. Ann Intern Med 119:1168-1174, 1993 (Pubitemid 23361446)
10. Walshe LJ, Malak SF, Eagan J, et al: Complication rates among cancer patients with peripherally inserted central catheters. J Clin Oncol 20:3276-3281, 2002 (Pubitemid 34831526)
11. Warren JL, Klabunde CN, Schrag D, et al: Overview of the SEER-Medicare data: Content, research applications, and generalizability to the United States elderly population. Med Care 40:IV3-IV18, 2002 (suppl)
12. American College of Radiology: Major restructuring of central venous access codes for 2004. http://www.acr.org/Advocacy/Economics-Health-Policy/ Billing-Coding/Coding-Source-List/2003/Nov-Dec-2003/Major-Restructuring-of- Central-Venous-Access-Codes-for-2004
13. Wright SB, Huskins WC, Dokholyan RS, et al: Administrative databases provide inaccurate data for surveillance of long-term central venous catheterassociated infections. Infect Control Hosp Epidemiol 24:946-949, 2003 (Pubitemid 38029563)
14. Romano PS, Roos LL, Jollis JG: Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: Differing perspectives. J Clin Epidemiol 46:1075-1079, 1993; discussion 1081-1090
15. Klabunde CN, Potosky AL, Legler JM, et al: Development of a comorbidity index using physician claims data. J Clin Epidemiol 53:1258-1267, 2000 (Pubitemid 32007842)
16. Warren JL, Harlan LC, Fahey A, et al: Utility of the SEER-Medicare data to identify chemotherapy use. Med Care 40:IV55-IV61, 2002 (suppl)
17. Cooper GS, Virnig B, Klabunde CN, et al: Use of SEER-Medicare data for measuring cancer surgery. Med Care 40:IV43-IV8, 2002 (suppl)
18. Virnig BA, Warren JL, Cooper GS, et al: Studying radiation therapy using SEER-Medicare-linked data. Med Care 40:IV49-IV54, 2002 (suppl)
19. Rubin DB: Estimating causal effects from large data sets using propensity scores. Ann Intern Med 127:757-763, 1997
20. Tomlinson D, Mermel LA, Ethier MC, et al: Defining bloodstream infections related to central venous catheters in patients with cancer: A systematic review. Clin Infect Dis 53:697-710, 2011
21. Tehrani DM, Russell D, Brown J, et al: Discord among performance measures for central line-associated bloodstream infection. Infect Control Hosp Epidemiol 34:176-183, 2013
22. Sherman ER, Heydon KH, St John KH, et al: Administrative data fail to accurately identify cases of healthcare-associated infection. Infect Control Hosp Epidemiol 27:332-337, 2006 (Pubitemid 43736095)
23. Cancer Action Network, American Cancer Society: Cancer and Medicare: A Chartbook. http://www.allhealth.org/briefingmaterials/ CancerandMedicareChartbookFinalfulldocumentMarch11-1412.pdf
24. Thomas EJ, Brennan TA: Incidence and types of preventable adverse events in elderly patients: Population based review of medical records. BMJ 320:741-744, 2000 (Pubitemid 30179420)